Reply.

Tuhina Neogi Nicola Dalbeth Ted R Mikuls Amy S Turner John D FitzGerald

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2021)

We contest the presumption by Drs. Kolber and Tan that rheumatologists value surrogate markers over "patient oriented outcomes (like gout flares) in guiding clinical decisions."( A&R LTE by Kolber and Tan) Rheumatologists are fully aware and agree that flares are the central experience of gout, and preventing flares, tophi and joint damage is the major focus of gout management.

Keyphrases

uric acid
metabolic syndrome
case report
oxidative stress
type diabetes
insulin resistance